Literature DB >> 2276390

Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics.

B Bruguerolle1, M Toumi, F Faraj, D Vervloet, H Razzouk.   

Abstract

The effect of menstrual cycle on the pharmacokinetics of theophylline has been studied in 9 female asthmatic patients. At three different times during the cycle (first, tenth and twentieth days) each subject received an i.v. infusion of 240 mg theophylline. Significant changes were found in the kinetics of theophylline according to the menstrual cycle. The maximum plasma drug concentration, minimum mean residence time, and minimum elimination half-life were observed at mid-cycle. The lowest clearance was observed at D 20. The AUC and volume of distribution did not vary significantly during the cycle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276390     DOI: 10.1007/bf02657059

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Alcohol effects in women during the menstrual cycle.

Authors:  B M Jones; M K Jones
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  The effects of estrus cycle on drug metabolism in the rat.

Authors:  Y Brandstetter; J Kaplanski; V Leibson; Z Ben-Zvi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Oct-Dec       Impact factor: 2.441

3.  [Changes in the pharmacokinetics of drugs during the menstrual cycle].

Authors:  B Bruguerolle
Journal:  Therapie       Date:  1986 Jan-Feb       Impact factor: 2.070

4.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

5.  Effect of chronic oral contraceptive steroids on theophylline disposition.

Authors:  K M Tornatore; R Kanarkowski; T L McCarthy; M J Gardner; A M Yurchak; W J Jusko
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

6.  Phenytoin pharmacokinetics in catamenial epilepsy.

Authors:  G Shavit; P Lerman; A D Korczyn; S Kivity; M Bechar; S Gitter
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

Review 7.  Pharmacokinetic drug interactions with theophylline.

Authors:  J H Jonkman; R A Upton
Journal:  Clin Pharmacokinet       Date:  1984 Jul-Aug       Impact factor: 6.447

8.  Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases.

Authors:  J Wójcicki; B Gawrońska-Szklarz; J Kazimierczyk; Z Baskiewicz; A Raczyński
Journal:  Arzneimittelforschung       Date:  1979

9.  Sex differences in absorption kinetics of sodium salicylate.

Authors:  S L Miaskiewicz; C A Shively; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

10.  The influence of the menstrual cycle on the metabolism and clearance of methaqualone.

Authors:  K Wilson; M Oram; C E Horth; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

View more
  10 in total

Review 1.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

Review 2.  Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  A D Kashuba; A N Nafziger
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

3.  Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations.

Authors:  Khaled Abduljalil; Iain Gardner; Masoud Jamei
Journal:  Front Pediatr       Date:  2022-05-12       Impact factor: 3.569

Review 4.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

5.  Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected Women.

Authors:  Charles E Frost; John Adams; Mark Shelton; Abdel-Hameed I Mohammed Ebid; Lawrence J Gugino; Ross Hewitt; Robin Difrancesco; Elizabeth Ingalls; Stephen Cousins; J Hu; Gene D Morse
Journal:  Clin Drug Investig       Date:  2002       Impact factor: 2.859

6.  Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.

Authors:  K H Lew; E A Ludwig; M A Milad; K Donovan; E Middleton; J J Ferry; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1993-10       Impact factor: 6.875

Review 7.  Gender differences in pharmacokinetics.

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 8.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 9.  Theophylline. Current thoughts on the risks and benefits of its use in asthma.

Authors:  S S Nasser; P J Rees
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

10.  Pharmacokinetics of droloxifene in mice, rats, monkeys, premenopausal and postmenopausal patients.

Authors:  Y Tanaka; M Sekiguchi; T Sawamoto; T Hata; Y Esumi; S Sugai; S Ninomiya
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.